Estimating viral titres in solutions with low viral loads

被引:13
作者
Brownie, C.
Statt, J. [1 ]
Bauman, P. [1 ]
Buczynski, G. [1 ]
Skjolaas, K. [2 ]
Lee, D. [1 ]
Hotta, J. [1 ]
Roth, N. J. [1 ]
机构
[1] Talecris Biotherapeut, Pathogen Safety, Res Triangle Pk, NC 27709 USA
[2] Talecris Biotherapeut, Regulatory Affairs, W Clayton, NC 27520 USA
关键词
Most probable number; TCID(50) assay; Single-hit Poisson model; Spearman-Karber; Virus titre; Maximum likelihood; ASSAYS;
D O I
10.1016/j.biologicals.2011.06.007
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
An important consideration in the manufacture of products derived from animal or human sources is the virus reduction capacity of the manufacturing process as estimated using validated bench-scale models of relevant manufacturing steps. In these studies, manufacturing process intermediates are spiked with virus and processed using the bench-scale model and the resulting viral titres of input and output samples are typically determined using cell-based infectivity assays. In these assays, the SpearmanKarber (SK) method is commonly used to estimate titres when there is one or more positive observation (i.e., the presence of any viral cytopathic effect). The SK method is most accurate when the proportion of positive observations ranges from < 0.1 to > 0.9 across dilutions but can be biased otherwise. Maximum likelihood (ML) based on a single-hit Poisson model is an alternative widely used estimation method. We compared SK with ML and found the methods to have similar properties except for situations in which the concentration of virus is low but measurable. In this case, the SK method produces upwardly biased estimates of titres. Based on our results, we recommend the use of either ML or SK at most virus concentrations; however, at low virus concentrations ML is preferred. (C) 2011 The International Alliance for Biologicals. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:224 / 230
页数:7
相关论文
共 16 条
[11]   One-hit models for virus inactivation studies [J].
Kundi, M .
ANTIVIRAL RESEARCH, 1999, 41 (03) :145-152
[12]   Improvements in methods for calculating virus titer estimates from TCID50 and plaque assays [J].
LaBarre, DD ;
Lowy, RJ .
JOURNAL OF VIROLOGICAL METHODS, 2001, 96 (02) :107-126
[13]   Design and analysis of serial limiting dilution assays with small sample sizes [J].
Macken, C .
JOURNAL OF IMMUNOLOGICAL METHODS, 1999, 222 (1-2) :13-29
[14]   DILUTION ASSAY STATISTICS [J].
MYERS, LE ;
MCQUAY, LJ ;
HOLLINGER, FB .
JOURNAL OF CLINICAL MICROBIOLOGY, 1994, 32 (03) :732-739
[15]   ACCURACY OF THE END-POINT ASSAY FOR VIRUS TITRATION [J].
NIELSEN, LK ;
SMYTH, GK ;
GREENFIELD, PF .
CYTOTECHNOLOGY, 1992, 8 (03) :231-236
[16]  
*SAS I, 2000, SAS C ONL